What was Bora Pharmaceuticals' revenue in May 2026?

Bora Pharmaceuticals' revenue in May 2026 was NT$2.114 billion.

By what percentage did Bora Pharmaceuticals' revenue grow year-over-year in May 2026?

Bora Pharmaceuticals' revenue grew by 40.19% year-over-year in May 2026.

Which company acquired the US health brand Weider in the Bora Pharmaceuticals group?

Sunway Biotech, a subsidiary of Bora Pharmaceuticals, acquired the US health brand Weider.

What business segment contributed to Bora Pharmaceuticals' recovery besides the Weider acquisition?

The CDMO (Contract Development and Manufacturing Organization) business contributed to Bora's recovery.

When did Bora Pharmaceuticals report record-high revenue following Q1 challenges?

Bora Pharmaceuticals reported record-high revenue in May 2026 following Q1 challenges.

AI News NQ Analysis

Bora Pharmaceuticals Hits Record High May Revenue, Shaking Off Q1 Headwinds with CDMO Recovery and Weider Acquisition

NQ Score 88/100

N1 Content Completeness 90

AI Summary (NQ-processed)

Bora Pharmaceuticals announced that its May 2026 revenue reached NT$2.114 billion, a record high and a 40.19% year-over-year increase. The primary growth drivers were the inclusion of US health brand Weider, acquired by its subsidiary Sunway Biotech, and a recovery in its CDMO (Contract Development and Manufacturing Organization) business utilization. The company stated that its operations are gradually moving past the headwinds faced in the first quarter.

AI Analysis

Frequently Asked Questions

Q: What was Bora Pharmaceuticals' revenue in May 2026?: A: Bora Pharmaceuticals' revenue in May 2026 was NT$2.114 billion.
Q: By what percentage did Bora Pharmaceuticals' revenue grow year-over-year in May 2026?: A: Bora Pharmaceuticals' revenue grew by 40.19% year-over-year in May 2026.
Q: Which company acquired the US health brand Weider in the Bora Pharmaceuticals group?: A: Sunway Biotech, a subsidiary of Bora Pharmaceuticals, acquired the US health brand Weider.
Q: What business segment contributed to Bora Pharmaceuticals' recovery besides the Weider acquisition?: A: The CDMO (Contract Development and Manufacturing Organization) business contributed to Bora's recovery.
Q: When did Bora Pharmaceuticals report record-high revenue following Q1 challenges?: A: Bora Pharmaceuticals reported record-high revenue in May 2026 following Q1 challenges.